Human Thalamus in Propagation of Temporal Lobe Seizures and Memory Formation
Part of paid clinical trials in Stanford, California.
- Sponsor
- Stanford University
- Study ID
- NCT07226908
- Status
- Enrolling By Invitation
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 65 Years
- Healthy Volunteers
- Not accepted
Interventions
- Cognitive experiment — OTHERRecord brain activity during memory encoding
- Electrical stimulation of the brain — OTHERMeasure accuracy and reaction time during cognitive tasks
Study Details
The goal of the study is to examine how two key subregions of the human thalamus (ANT and PLV) are connected with other brain structures (Aim 1), how seizures involve the two thalamic subregions differently and how the map of cortico-thalamic ictal propagation matches the intrinsic connectivity maps identified in the same individuals (Aim 2), and the effect of ANT and PLV stimulations on memory formation (Aim 3).
Key Dates
- Start date
- Sep 1, 2024
- Status verified
- Aug 2025
- Primary completion
- Aug 31, 2029
- Completion
- Aug 31, 2029
Study Design
- Enrollment
- 100 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- BASIC_SCIENCE
Arms
- Other: Epilepsy Patients with Thalamic Electrode ImplantsPatients will undergo cognitive testing and electrical stimulation experiments.
Primary Outcome Measure
Cerebro-cerebral evoked potentials [ Time Frame: During experiment up to 2 weeks ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Stanford Hospital | Stanford | California | 94304 | - |
Find similar trials in Stanford, CA
By condition
By specialty
By research site
Related Studies
- SLC13A5 Deficiency Natural History Study - Remote OnlyEnrolling By Invitation · TESS Research Foundation · Palo Alto, California
- Understanding Ketamine's Dissociative Effects (KD Study)PHASE1 · Recruiting · Stanford University · Palo Alto, California
- The Neural Coding of Speech Across Human LanguagesEnrolling By Invitation · University of California, San Francisco · San Francisco, California
- Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention StudyPHASE2 · Recruiting · Darcy Krueger · Birmingham, Alabama